Home › Funds › DME Capital Management, LP › SNX
DME Capital Management, LP position in SNX
TD SYNNEX CORPORATION · Technology
DME Capital Management, LP reported holding 381,042 shares of SNX (TD SYNNEX CORPORATION) in its Q2 2026 13F filing — a position valued at US$101.9M, representing 2.61% of its reported portfolio and ranking #11 among its reported holdings. DME Capital Management, LP has disclosed SNX holdings in 7 of the last 7 reported quarters, going back to Q4 2024.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How DME Capital Management, LP's SNX position evolved
DME Capital Management, LP first disclosed a stake in SNX in Q4 2024 at 53,780 shares (US$6.3M). The position peaked in Q2 2026 at 381,042 shares, worth US$101.9M. Across 7 filings, DME Capital Management, LP increased the stake 3 time(s), trimmed it 3 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 381,042 shares valued at US$101.9M — a reduction of -98,488 shares quarter over quarter.. Notable position changes include a 28% trim in Q2 2025 (shares rose 21% over the following quarter), a 45% increase in Q4 2025 (shares rose 12% over the following quarter), a 749% increase in Q1 2026 (shares rose 58% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2024 | 53.78K | $6.31M | New |
| Q1 2025 | 46.22K | $4.80M | Reduce |
| Q2 2025 | 33.27K | $4.51M | Reduce |
| Q3 2025 | 39.03K | $6.39M | Add |
| Q4 2025 | 56.49K | $8.49M | Add |
| Q1 2026 | 479.53K | $80.90M | Add |
| Q2 2026 | 381.04K | $101.87M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About SNX and 13F data
SNX (TD SYNNEX CORPORATION) is a Technology company. 52 other funds we track also report a position in SNX — the largest reported positions include ABRAMS BISON INVESTMENTS, LLC (US$540.5M), Ninety One UK Ltd (US$465.1M), Brave Warrior Advisors, LLC (US$385.4M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding SNX
- ABRAMS BISON INVESTMENTS, LLC 2.02M sh · $540.50M · Q2 2026
- Ninety One UK Ltd 1.81M sh · $465.10M · Q3 2026
- Brave Warrior Advisors, LLC 1.44M sh · $385.41M · Q2 2026
- LYRICAL ASSET MANAGEMENT LP 1.16M sh · $309.37M · Q2 2026
- THRIVENT FINANCIAL FOR LUTHERANS 932.47K sh · $249.29M · Q2 2026
- SILVERCREST ASSET MANAGEMENT GROUP LLC 638.87K sh · $170.80M · Q2 2026
- Freestone Grove Partners LP 369.00K sh · $98.65M · Q2 2026
More on DME Capital Management, LP
FAQ
How long has DME Capital Management, LP held SNX?
DME Capital Management, LP has disclosed SNX holdings in 7 of the last 7 reported quarters, going back to Q4 2024.
What is DME Capital Management, LP's current position in SNX?
As of Q2 2026, DME Capital Management, LP holds 381.04K shares of SNX (TD SYNNEX CORPORATION), valued at $101.87M, representing 2.61% of its reported portfolio and ranking #11.
Has DME Capital Management, LP been buying or selling SNX?
In the latest 13F filing (Q2 2026), DME Capital Management, LP reduced its position in SNX. The position peaked in Q2 2026 at 381.04K shares.
Which other funds hold SNX?
Other major institutional holders of SNX include ABRAMS BISON INVESTMENTS, LLC, Ninety One UK Ltd, Brave Warrior Advisors, LLC, among 52 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.